Free provider profile
AMANDA RIGGINS, FNP-BC
Need more providers like AMANDA RIGGINS?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What AMANDA RIGGINS prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Trelegy Ellipta
- Breo Ellipta
- Breztri Aerosphere
- Stiolto Respimat
- Symbicort
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
615-941-8550
Fax
615-941-8507
Practice address
300 20TH AVE N STE G1, NASHVILLE, TN, 37203
- Registry updated
- 2026-09-09
- NPI issued
- 2021-02-26
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
300 20TH AVE N STE G1, NASHVILLE, TN, 37203
615-941-8550
Single practice location
Enumerated 2021-02-26
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record updated within the last year.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,444
Medicare patients
236
Part D drug cost
$522,758
Brand-name share
54.2%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 215 | $166,927 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | 69 | $48,897 |
| Breo Ellipta (Fluticasone/Vilanterol) | 71 | $30,535 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | 45 | $22,257 |
| Spiriva Respimat (Tiotropium Bromide) | 33 | $16,211 |
| Combivent Respimat (Ipratropium/Albuterol Sulfate) | 16 | $12,056 |
| Symbicort (Budesonide/Formoterol Fumarate) | 38 | $11,408 |
| Budesonide-Formoterol Fumarate (Budesonide/Formoterol Fumarate) | 26 | $6,698 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across TN — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
